Can-Fite BioPharma Ltd. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $75.00K 20-F · filed 2023-03-30 | |
| 2019-12-31 | $115.00K 20-F · filed 2022-03-24 | |
| 2018-12-31 | $282.00K 20-F · filed 2021-03-25 | |
| 2017-12-31 | $95.00K 6-K · filed 2020-06-01 |